BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 2719763)

  • 1. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
    Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
    Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
    Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
    Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
    Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
    Gupta R; Vasisht S; Bahl VK; Wasir HS
    Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
    Nieminen MS; Mattila KJ; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen MR
    Arterioscler Thromb; 1992 Jan; 12(1):58-69. PubMed ID: 1346250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease.
    Nikkilä M; Solakivi T; Lehtimäki T; Koivula T; Laippala P; Aström B
    Atherosclerosis; 1994 Apr; 106(2):149-57. PubMed ID: 8060376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of apolipoproteins A-1 and B in Indian patients with angiographically defined coronary artery disease.
    Bahl VK; Vaswani M; Thatai D; Wasir HS
    Int J Cardiol; 1994 Sep; 46(2):143-9. PubMed ID: 7814163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid abnormalities in Greek patients with coronary artery disease.
    Elisaf MS; Siamopoulos KC; Tselegarides TJ; Bairaktari ETh ; Goudevenos JA; Tselepis AD; Tsolas OE; Sideris DA
    Int J Cardiol; 1997 Apr; 59(2):177-84. PubMed ID: 9158172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of plasma lipid and lipoprotein profiles in hypertensive black versus white men. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Lakshman MR; Reda D; Materson BJ; Cushman WC; Kochar MS; Nunn S; Hamburger RJ; Freis ED
    Am J Cardiol; 1996 Dec; 78(11):1236-41. PubMed ID: 8960581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.